Connect and Interact with Industry, Academia, and Regulatory Experts from Around the World.

-----------------------------------------

Nonclinical and Clinical Strategies in First-in-Human Dosing of Large and Small Molecules
April 4-6 | Washington, DC

DIA/FDA Quantitative Structure-activity Relationship (Q)SAR Approaches to Assessing Genotoxic Impurities in Pharmaceuticals
April 7 | Rockville, MD

FDA/DIA Statistics Forum 2011
April 10-13 | North Bethesda, MD

Latin American Regulatory Conference (LARC) 2011
April 12-15 | Panama City, Panama

Cardiovascular Safety in Drug Development: State-of-the-art Assessments
April 13-15 | Washington, DC

Dried Blood Spot Sampling in the Pharmaceutical Industry: Three Years of Experience and Implementation
May 3-4 | Philadelphia, PA

The Future of Biosimilars in the US: Legal, Regulatory, Scientific, Regulatory, Clinical and Payer Issues
May 4-5 | North Bethesda, MD

FDA Information Day: The New Individual Case Safety Report (ICSR) International Standard and ICH E2B
May 12-13 | Alexandria, VA

DIA 2011
47th Annual Meeting
June 19-23 | Chicago, IL

COMING SOON:

13th International Paul-Ehrlich Seminar
September 14-17 | Washington, DC

The Rare Diseases Summit 2011
October 11-13 | Washington, DC